KClavis Science New Technology Fund, Life Science Consortium No. 1, Life Science Consortium No. 2, Preston Partners Co., Ltd, Byron Co., Ltd and Third Party Investment Fund 1 signed a contract to acquire 69.38% stake in Ndfos Co.,Ltd. (KOSDAQ:A238090) from Neo Tech Co., Ltd., Dabo Trading Co., Ltd., Hotak Yoon, Jaesik Yoon and Haesook Bae for KRW 92 billion on October 1, 2018. Under the terms of the contract, 10.5 million shares of Ndfos will be acquired at KRW 8800 per share. KRW 10 billion will be paid on October 01, 2018 as down payment and the remaining will be paid on November 02, 2018. KClavis Science, Life Science Consortium No. 1, Life Science Consortium No. 2, Preston Partners, Byron Co., Ltd and Third Party Investment Fund 1 will acquire 35.4% (5.3 million shares), 9.8% (1.5 million shares), 9.8% (1.5 million shares), 4.9% (0.74 million shares), 4.9% stake (0.74 million shares) and 4.54% (0.68 million shares) respectively. Neo Tech, Dabo Trading, Hotak Yoon, Jaesik Yoon and Haesook Bae will sell 44.3%, 8%, 12.6%, 4.1% and 0.4% respectively. The transaction is expected to close on November 2, 2018. As of October 1, 2018, Life Science Consortium No. 1 completed the acquisition of 9.8% stake in Ndfos Co.,Ltd. from Neo Tech Co., Ltd., Jaesik Yoon and DABO Trading Co., Ltd. As of October 1, 2018, Life Science Consortium No. 2 completed the acquisition of 9.8% stake in Ndfos Co.,Ltd. from Neo Tech Co., Ltd. and DABO Trading Co., Ltd.